Lesley Ann Calhoun's Net Worth

$2.1 Million

Estimate Recalculated Jul 2, 2024 07:57PM EST

Who is Lesley Ann Calhoun?

Lesley Ann Calhoun has an estimated net worth of $2.1 Million. This is based on reported shares across multiple companies, which include Tango Therapeutics, Inc., Global Blood Therapeutics, Inc., and Aligos Therapeutics, Inc..

SEC CIK

Lesley Ann Calhoun's CIK is 0001730866

Past Insider Trading and Trends

2018 was Lesley Ann Calhoun's most active year for acquiring shares with 10 total transactions. Lesley Ann Calhoun's most active month to acquire stocks was the month of January. 2018 was Lesley Ann Calhoun's most active year for disposing of shares, totalling 14 transactions. Lesley Ann Calhoun's most active month to dispose stocks was the month of July. 2020 saw Lesley Ann Calhoun paying a total of $613,208.80 for 229,935 shares, this is the most they've acquired in one year. In 2020 Lesley Ann Calhoun cashed out on 60,054 shares for a total of $2,277,151.09, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tango Therapeutics, Inc. (TNGX) Snapshot price: $12.73

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+225.00%
11.25K
$7.21
$36,039.00
6.25K
Jun 5
Form 4
∞
5K
—
—
5K
Jun 6
Form 4
—
0
—
—
0
Jun 8
Form 3
—
0
—
—
0
No matching records found

Global Blood Therapeutics, Inc. No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$49.93
-$108,945.00
154
May 26
Form 4
—
0
$48.34
-$1,228,791.10
154
May 18
Form 4
-95.63%
-3.37K
$78.23
-$263,868.11
154
May 11 - May 12
Form 4
+5.88%
196
$63.96
-$6,651.84
3.53K
Mar 1
Form 4
+275.54%
2.44K
$50.97
-$75,310.04
3.33K
Jan 31 - Feb 3
Form 4
-75.71%
-2.77K
$54.36
-$150,296.28
887
Sep 11
Form 4
+5.67%
196
$45.98
-$4,781.92
3.65K
Sep 1
Form 4
+181.43%
2.23K
$45.47
-$57,505.00
3.46K
Jul 31 - Aug 1
Form 4
+18.99%
196
$53.48
-$5,561.92
1.23K
Mar 1
Form 4
—
0
$43.57
-$4,875.64
1.03K
Jan 31 - Feb 12
Form 4
+42.84%
443
$48.44
-$14,871.08
1.48K
Feb 1
Form 4
+23.39%
196
$48.95
-$5,090.80
1.03K
Sep 1 - Sep 4
Form 4
-26.36%
-300.00
$36.76
-$59,722.21
838
Jul 31 - Aug 17
Form 4
+193.30%
750
—
—
1.14K
Aug 1
Form 4
—
0
$33.10
-$73,123.83
388
Jul 6 - Jul 9
Form 4
+107.49%
201
$60.35
-$5,974.65
388
Mar 1 - Mar 5
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found

Aligos Therapeutics, Inc. (ALGS) Snapshot price: $0.6899

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Feb 27 - Feb 28
Form 4
—
0
—
—
0
Sep 8
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Jul 7
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
Dec 1
Form 3
—
0
—
—
0
No matching records found